Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors

Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors

Immune checkpoint inhibitors have revolutionized cancer management. Some patients with gastrointestinal (GI) tract malignancy have experienced remarkable results. Here, in our review, we discuss predictive/prognostic GI tumor biomarkers that appear to correlate with benefits with this strategy. Rema...

Full description

Bibliographic Details
Main Authors: Jane E. Rogers, Kohei Yamashita, Matheus Sewastjanow Silva, Jaffer A. Ajani
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
gastrointestinal neoplasms
immune checkpoint inhibitor
microsatellite-instability-high/deficient mismatch repair
programmed-death-1
programmed death-ligand-1
Online Access:https://www.mdpi.com/2072-6694/14/19/4804

Internet

https://www.mdpi.com/2072-6694/14/19/4804

Similar Items